Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TIC Gums is a global leader in advanced texture and stabilization solutions for the food, beverage, and pharmaceutical industries. The company specializes in hydrocolloid technology, providing a wide range of gums and stabilizers including gum arabic, guar gum, and xanthan gum. In the pharmaceutical sector, TIC Gums offers high-quality excipients used for binding, thickening, and stabilizing various dosage forms. Following its acquisition by Ingredion in 2016, the company continues to operate as a specialized business unit focusing on innovative texture systems. Their expertise includes clean-label solutions and customized stabilizer blends for complex formulations. The company is also recognized for its technical support and educational initiatives like Gum University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TIC Gums.